Let us know how we can continue the conversation. More >>
Come see us at the first fully virtual ERA-EDTA Congress
June 6-9, 2020 • Booth 51
Advancing fluorescent technology to help improve patient care.
MediBeacon is a medical technology company specializing in the advances of fluorescent tracer agents and transdermal measurement. The science is complex, but the outcomes are simple to understand. How it works >>
MediBeacon technology is available for preclinical use.
MediBeacon technologies are progressing through clinical trials.*
There are no limits to our thinking or what that thinking can accomplish.
Focus areas for fluorescent agent- based systems include:
Point of care measurement of renal function ** -Learn More
Point of care gastrointestinal
permeability measurement -Learn More
Clinicians have limited tools to identify patients at risk of AKI
Identification of high-risk patients preoperatively could affect clinical decision making
- The Society of Thoracic Surgeons, Mitchell Rosner, John Kellum, and Claudio Ronco et al., Preoperative renal functional reserve predicts risk of Acute Kidney Injury (AKI) after cardiac operation, 2018
MediBeacon’s Transdermal Glomerular Filtration Rate Measurement System (TGFR) has the potential to provide important information to cardiologists to address this challenge.
THE UNMET MEDICAL NEED IN THE INTENSIVE CARE UNIT:
Acute Kidney Injury occurred in more than
of ICU patients.
- Intensive Care Medicine, Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study, 2015
MediBeacon’s Transdermal Glomerular Filtration Rate Measurement System (TGFR) has the potential to provide important information to Intensive Care Unit professionals to address this challenge.
Follow the progress: Sign up today to receive notifications of milestones, news and updates on MediBeacon fluorescent technology.
United States 1100 Corporate Square Drive
St. Louis, MO 63132
P: (314) 269-5808
*MediBeacon products are in various stages of clinical development and are not yet approved for human use.
**The Transdermal GFR Measurement System (TGFR) is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function. References on this website to measured kidney function and measured renal function refer to the measured GFR.